Evidence Hub

Psychosis as a side effect of COVID-19 vaccine administration – a case series

G. Guerrero, C. Morillo, C. Carrillo

Neuroscience Applied, 2022

80 participants

Abstract

s NEUROSCIENCE APPLIED 1 (2022) 100112 comorbid clinical symptoms and disorders. Transition rate from CHR to full psychosis in untreated cohorts is not known. In some patients, persistent comorbid symptoms could indicate a prolonged prodromal phase and increased risk of late transition. Although treatment in CHR patients focuses mainly on interventions aiming to decrease the risk of transition, comorbid symptoms and disorders, which often tend to persist over a long period and contribute to psychosocial impairment, must not be neglected in the monitoring and treatment of CHR patients. Future research could also identify potential critical intervention points where success may alter the life course of illness. No conflict of interest doi: https://doi.org/10.1016/j.nsa.2022.100571 P.0512 NEUROSCIENCE APPLIED 1 (2022) 100112 100572 Psychosis as a side effect of COVID-19 vaccine administration – a case series G. P erez Guerrero , C. L opez Morillo , C. Manzorro Carrillo . 1Hospital Regional Universitario de M alaga, Psychiatry, Malaga, Spain Background: The COVID-19 pandemic has had a major impact on people's mental health, being a significant psychological stressor that has precipitated anxiety and stress-related disorders [1], [2]. However, it is being studied how the virus itself can generate neuropsychiatric symptoms such as psychotic or confusional ones [1], [2], [3]. The pathogenic mechanisms underlying the psychiatric manifestations are not clear but there are different…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free